Viral characteristics and clinical presentation in dengue co-infection- Findings from a facility based observational study in Odisha, India.
Co-infection
dengue
phylogeny
serology
Journal
Journal of family medicine and primary care
ISSN: 2249-4863
Titre abrégé: J Family Med Prim Care
Pays: India
ID NLM: 101610082
Informations de publication
Date de publication:
Aug 2021
Aug 2021
Historique:
received:
04
12
2020
revised:
21
02
2021
accepted:
23
03
2021
entrez:
18
10
2021
pubmed:
19
10
2021
medline:
19
10
2021
Statut:
ppublish
Résumé
Dengue has affected many countries globally. Two-fifths part of the world is at risk, which can be affected by dengue disease. In India, the dengue incidence has increased in the recent past and emerged as an important health problem in many states including Odisha. Dengue disease presents with atypical clinical symptoms when associated with other co-infections. A facility-based longitudinal study was carried out over a period of 1 year to determine the dengue co-infection and its outcome. The suspected cases were clinically assessed following a standard case report format and serological investigations including serotyping were carried out. 33.6% samples were dengue positive of which 78.5% were positive for NS1 Ag, 26.6% positive for dengue IgM and 5.1% to both. Among the dengue positive cases, 60.9% were male and mean age was 31.52 (±17.03) years. High occurrence of cases was during May to November with maximum in August. Among the 975 dengue positives, 57 (5.8%) were found to have co-infection. Chikungunya was the most common co-infection in 71.9%, followed by herpes simplex (HSV) (7%) and other diseases. Fever was the most common presenting symptom (98.2%), followed by myalgia (91.2%), retro orbital pain (91.2%), pain abdomen (12.3%), rash/lesion (8.8%), burning micturition (5.3%), petechiae (1.7%) and pruritus (1.7%) among the co-infected cases. All the four dengue serotypes were found to be circulating with DEN 2 as the most predominant one. About 5.8% of dengue cases have co-infection (mainly with Chikungunya) and clinically present with atypical signs and symptoms.
Sections du résumé
BACKGROUND
BACKGROUND
Dengue has affected many countries globally. Two-fifths part of the world is at risk, which can be affected by dengue disease. In India, the dengue incidence has increased in the recent past and emerged as an important health problem in many states including Odisha. Dengue disease presents with atypical clinical symptoms when associated with other co-infections.
MATERIALS AND METHODS
METHODS
A facility-based longitudinal study was carried out over a period of 1 year to determine the dengue co-infection and its outcome. The suspected cases were clinically assessed following a standard case report format and serological investigations including serotyping were carried out.
RESULTS
RESULTS
33.6% samples were dengue positive of which 78.5% were positive for NS1 Ag, 26.6% positive for dengue IgM and 5.1% to both. Among the dengue positive cases, 60.9% were male and mean age was 31.52 (±17.03) years. High occurrence of cases was during May to November with maximum in August. Among the 975 dengue positives, 57 (5.8%) were found to have co-infection. Chikungunya was the most common co-infection in 71.9%, followed by herpes simplex (HSV) (7%) and other diseases. Fever was the most common presenting symptom (98.2%), followed by myalgia (91.2%), retro orbital pain (91.2%), pain abdomen (12.3%), rash/lesion (8.8%), burning micturition (5.3%), petechiae (1.7%) and pruritus (1.7%) among the co-infected cases.
CONCLUSIONS
CONCLUSIONS
All the four dengue serotypes were found to be circulating with DEN 2 as the most predominant one. About 5.8% of dengue cases have co-infection (mainly with Chikungunya) and clinically present with atypical signs and symptoms.
Identifiants
pubmed: 34660431
doi: 10.4103/jfmpc.jfmpc_2380_20
pii: JFMPC-10-2958
pmc: PMC8483126
doi:
Types de publication
Journal Article
Langues
eng
Pagination
2958-2963Informations de copyright
Copyright: © 2021 Journal of Family Medicine and Primary Care.
Déclaration de conflit d'intérêts
There are no conflicts of interest.
Références
IDCases. 2016 Jul 29;5:67-8
pubmed: 27516967
BMC Infect Dis. 2019 Aug 1;19(1):680
pubmed: 31370795
Infect Genet Evol. 2015 Oct;35:134-41
pubmed: 26247719
PLoS Negl Trop Dis. 2018 Jun 6;12(6):e0006561
pubmed: 29874242
Mol Biol Evol. 2013 Dec;30(12):2725-9
pubmed: 24132122
Emerg Infect Dis. 2006 Oct;12(10):1580-3
pubmed: 17176577
J Mol Evol. 1980 Dec;16(2):111-20
pubmed: 7463489
J Clin Microbiol. 1992 Mar;30(3):545-51
pubmed: 1372617
Scientifica (Cairo). 2016;2016:6391594
pubmed: 27213083
Euro Surveill. 2016 Jun 2;21(22):
pubmed: 27277216
Emerg Infect Dis. 2016 Nov;22(11):2003-2005
pubmed: 27767914
Int J Infect Dis. 2018 Sep;74:41-46
pubmed: 30100535
BMC Infect Dis. 2019 Jul 3;19(1):572
pubmed: 31269906
Ci Ji Yi Xue Za Zhi. 2018 Jul-Sep;30(3):158-164
pubmed: 30069124
Mol Biol Evol. 1987 Jul;4(4):406-25
pubmed: 3447015
Indian J Crit Care Med. 2019 Jun;23(6):270-273
pubmed: 31435145
Clin Microbiol Rev. 1998 Jul;11(3):480-96
pubmed: 9665979
PLoS Negl Trop Dis. 2018 Jul 16;12(7):e0006618
pubmed: 30011275
Indian J Med Res. 2005 Jan;121(1):36-8
pubmed: 15713977
PLoS Negl Trop Dis. 2017 Sep 13;11(9):e0005859
pubmed: 28902845
Evolution. 1985 Jul;39(4):783-791
pubmed: 28561359
J Family Med Prim Care. 2019 Mar;8(3):1022-1027
pubmed: 31041245
J Lab Physicians. 2018 Oct-Dec;10(4):443-447
pubmed: 30498319
Infect Dis Poverty. 2019 May 6;8(1):31
pubmed: 31056077
Indian J Med Res. 2014 Nov;140(5):660-4
pubmed: 25579149